Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging

J Neurosci
24 December 2008
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844750/

Paul Battle PA-C - Potential Applications for LDN (2013 Conference) (LDN, low dose naltrexone)

Sakina Davis, MD - Hashimotos and LDN (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Hypothyroidism - Dawn Ipsen, PharmD (2021 Conference) (LDN, low dose naltrexone)

Dr. Dawn Ipsen is a compounding pharmacist who presents on some roles low dose naltrexone (LDN) may have in helping patients with hypothyroidism. She discusses hypothyroidism, its prevalence, and treatment goals.